Ocuphire Pharma
mean pupil diameter over time by mydriatic agent | Ocuphire Pharma
Company
Deck Type
Deck date
January 2022
Slide
55 of 114
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Results
March 2022
mean pupil diameter over time by eye color | Ocuphire Pharma
Results
March 2022
mean pupil diameter over time by mydriatic agents | Ocuphire Pharma
Results
March 2022
mean pupil diameter over time | Ocuphire Pharma
Results
March 2022
comparison of one drop fellow eye with two drops study eye | Ocuphire Pharma
Related slides by other companies
ATAI
Investor Conference
May 2023
phase trial design randomized week study of and placebo in patients with | ATAI
Fusion Pharmaceuticals
Investor Presentation
January 2024
fusion aligns with on potential registrational pathway a | Fusion Pharmaceuticals
Bausch+Lomb
Results
June 2022
investigational first in class treatment for dry eye disease associated with gland dysfunction | Bausch+Lomb
MindMed
Investor Presentation
December 2024
phase trial schematic schematic week a dose optimization study of | MindMed
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights